Preoperative versus postoperative docetaxel-cisplatin- fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial

N. Fazio*, R. Biffi, R. Maibach, S. Hayoz, S. Thierstein, P. Brauchli, J. Bernhard, R. Stupp, B. Andreoni, G. Renne, C. Crosta, R. Morant, A. Chiappa, F. Luca, M. G. Zampino, O. Huber, A. Goldhirsch, F. de Braud, A. D. Roth, U. PaceS. Cenciarelli, S. Pozzi, E. Bertani, S. Mura, K. Lorizzo, G. Di Meglio, D. Ravizza, S. Boselli, M. Matter, M. Richter, S. Monfardini, C. Dittrich, M. Häfner, M. Clemens, Susanne Crowe

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint Dive into the research topics of 'Preoperative versus postoperative docetaxel-cisplatin- fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial'. Together they form a unique fingerprint.

Medicine & Life Sciences